Archer Investment Corporation’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.59K | Hold |
297
| – | – | ﹤0.01% | 855 |
|
|
2025
Q1 | $4.42K | Hold |
297
| – | – | ﹤0.01% | 838 |
|
|
2024
Q4 | $3.93K | Hold |
297
| – | – | ﹤0.01% | 851 |
|
|
2024
Q3 | $4.22K | Hold |
297
| – | – | ﹤0.01% | 831 |
|
|
2024
Q2 | $3.84K | Hold |
297
| – | – | ﹤0.01% | 818 |
|
|
2024
Q1 | $4.13K | Hold |
297
| – | – | ﹤0.01% | 797 |
|
|
2023
Q4 | $4.24K | Hold |
297
| – | – | ﹤0.01% | 804 |
|
|
2023
Q3 | $4.6K | Hold |
297
| – | – | ﹤0.01% | 765 |
|
|
2023
Q2 | $4.67K | Hold |
297
| – | – | ﹤0.01% | 750 |
|
|
2023
Q1 | $4.9K | Hold |
297
| – | – | ﹤0.01% | 659 |
|
|
2022
Q4 | $4.63K | Hold |
297
| – | – | ﹤0.01% | 640 |
|
|
2022
Q3 | $3.85K | Hold |
297
| – | – | ﹤0.01% | 628 |
|
|
2022
Q2 | $4.17K | Hold |
297
| – | – | ﹤0.01% | 628 |
|
|
2022
Q1 | $4.25K | Sell |
297
-297
| -50% | -$4.25K | ﹤0.01% | 634 |
|
|
2021
Q4 | $8.91K | Buy |
594
+297
| +100% | +$4.46K | ﹤0.01% | 552 |
|
|
2021
Q3 | $4.87K | Hold |
297
| – | – | ﹤0.01% | 596 |
|
|
2021
Q2 | $5K | Sell |
297
-35
| -11% | -$589 | ﹤0.01% | 496 |
|
|
2021
Q1 | $6.06K | Hold |
332
| – | – | ﹤0.01% | 589 |
|
|
2020
Q4 | $6.04K | Hold |
332
| – | – | ﹤0.01% | 543 |
|
|
2020
Q3 | $5.92K | Sell |
332
-221
| -40% | -$3.94K | ﹤0.01% | 490 |
|
|
2020
Q2 | $9.92K | Hold |
553
| – | – | 0.01% | 435 |
|
|
2020
Q1 | $8K | Hold |
553
| – | – | 0.01% | 444 |
|
|
2019
Q4 | $11K | Hold |
553
| – | – | 0.01% | 445 |
|
|
2019
Q3 | $10K | Buy |
553
+297
| +116% | +$5.37K | 0.01% | 347 |
|
|
2019
Q2 | $5K | Hold |
256
| – | – | ﹤0.01% | 388 |
|
|
2019
Q1 | $5K | Buy |
+256
| New | +$5K | ﹤0.01% | 391 |
|